Recombinant Ki-67 antibody (AA 2200-2500)

Catalog No. ABIN7872354

The Mouse Monoclonal anti-Ki-67 antibody is suitable to detect Ki-67 in samples from Human. It has been validated for ELISA.

Quick Overview for Recombinant Ki-67 antibody (AA 2200-2500) (ABIN7872354)

Target: Ki-67 (MKI67) (Antigen Identified By Monoclonal Antibody Ki-67 (MKI67))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This Ki-67 antibody is un-conjugated

Application: ELISA

Grade: Carrier-free

Clone: RMKI67-9616

Product Details anti-Ki-67 Antibody

Binding Specificity: AA 2200-2500

Purpose: Recombinant MKI67 Antibody / Ki-67 (azide and preservative free)

Purification: Protein A/G affinity

Immunogen: A recombinant fragment (within amino acids 2200-2500) of human MKI67 protein was used as the immunogen for the recombinant MKI67 antibody.

Isotype: IgG2b, kappa

Application Details

Application Notes: Optimal dilution of the recombinant MKI67 antibody should be determined by the researcher.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Preservative: Azide free

Storage: -20 °C

Storage Comment: Aliquot the recombinant MKI67 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Target Details for Ki-67

Target: Ki-67 (MKI67) (Antigen Identified By Monoclonal Antibody Ki-67 (MKI67))

Alternative Name: MKI67

Background: Proliferation marker protein Ki-67 antigen is a nuclear, non-histone protein that is present in all stages of the cell cycle except G0. This characteristic makes Ki-67 an excellent marker for proliferating cells and is commonly used as one of the prognostic factors in cancer studies. A correlation has been demonstrated between Ki-67 index and the histo-pathological grade of neoplasms. Assessment of Ki-67 expression in renal and ureter tumors shows a correlation between tumor proliferation and disease progression, thus making it possible to differentiate high-risk patients. Ki-67 expression may also prove to be important for distinguishing between malignant and benign peripheral nerve sheath tumors. Ki-67 labeling index has been shown to be a prognostic marker in a number of neoplasms including grade II astrocytoma, oligodendroglioma, colon carcinoma, and breast carcinoma. In general, Ki-67 is a good marker of proliferating cell populations.

UniProt: P46013

Pathways: Glycosaminoglycan Metabolic Process